Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Fautrel

Showing results (11-20 of 370) with videos related to

Pageof 37
Sort By:
Expert Review of Clinical Immunology|April 17, 2018
Complications of adult-onset Still's disease and their managementStéphane Mitrovic, Bruno Fautrel
Joint Bone Spine|March 6, 2022
National reimbursement databases: Use and limitations for rheumatologic studiesJoanna Kedra, Bruno Fautrel
International Journal of Inflammation|May 22, 2012
Anti-Interleukin-1 Agents in Adult Onset Still's DiseaseCecilia Giampietro, Bruno Fautrel
La Revue Du Praticien|December 12, 2012
[Medico-economic aspects of management of patients with rheumatoid arthritis]Sabrina Dadoun, Bruno Fautrel
Journal of Clinical Medicine|July 2, 2021
Clinical Phenotypes of Adult-Onset Still's Disease: New Insights from Pathophysiology and Literature FindingsStéphane Mitrovic, Bruno Fautrel
Current Opinion in Rheumatology|February 15, 2002
Cost of illness studies in rheumatic diseasesBruno Fautrel, Francis Guillemin
Pharmacoeconomics|October 27, 2012
Cost effectiveness of therapeutic interventions in ankylosing spondylitis: a critical and systematic reviewCécile Gaujoux-Viala, Bruno Fautrel
Bulletin De L'Academie Nationale De Medecine|July 3, 2013
[Medical and economic aspects of rheumatoid arthritis]Bruno Fautrel, Cécile Gaujoux-Viala
Arthritis Research & Therapy|June 21, 2015
Response to 'Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis'Nathan Vastesaeger, Bruno Fautrel, Josef Smolen
Expert Review of Clinical Immunology|October 19, 2019
Reply to the Letter: 'Thrombotic microangiopathy in adult-onset Still's disease: the story is just beginning'Stéphane Mitrovic, Alexandre Hertig, Bruno Fautrel
Pageof 37

Showing results (11-20 of 370) with videos related to

Sort By:
Pageof 37
Expert Review of Clinical Immunology|April 17, 2018
Complications of adult-onset Still's disease and their managementStéphane Mitrovic, Bruno Fautrel
Joint Bone Spine|March 6, 2022
National reimbursement databases: Use and limitations for rheumatologic studiesJoanna Kedra, Bruno Fautrel
International Journal of Inflammation|May 22, 2012
Anti-Interleukin-1 Agents in Adult Onset Still's DiseaseCecilia Giampietro, Bruno Fautrel
La Revue Du Praticien|December 12, 2012
[Medico-economic aspects of management of patients with rheumatoid arthritis]Sabrina Dadoun, Bruno Fautrel
Journal of Clinical Medicine|July 2, 2021
Clinical Phenotypes of Adult-Onset Still's Disease: New Insights from Pathophysiology and Literature FindingsStéphane Mitrovic, Bruno Fautrel
Current Opinion in Rheumatology|February 15, 2002
Cost of illness studies in rheumatic diseasesBruno Fautrel, Francis Guillemin
Pharmacoeconomics|October 27, 2012
Cost effectiveness of therapeutic interventions in ankylosing spondylitis: a critical and systematic reviewCécile Gaujoux-Viala, Bruno Fautrel
Bulletin De L'Academie Nationale De Medecine|July 3, 2013
[Medical and economic aspects of rheumatoid arthritis]Bruno Fautrel, Cécile Gaujoux-Viala
Arthritis Research & Therapy|June 21, 2015
Response to 'Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis'Nathan Vastesaeger, Bruno Fautrel, Josef Smolen
Expert Review of Clinical Immunology|October 19, 2019
Reply to the Letter: 'Thrombotic microangiopathy in adult-onset Still's disease: the story is just beginning'Stéphane Mitrovic, Alexandre Hertig, Bruno Fautrel
Pageof 37